Randy L. Jensen
Professor
Department of Neurosurgery
Huntsman Cancer Institute
United States of America
Biography
Dr. Randy Jensen specializes in Neurosurgery, Brain Tumors, Skull Base Surgery, Neuro Trauma and Neurocritical Care. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.
Research Interest
Hypoxia, Brain Hypoxia Inducible Factor-1 Calcium Channel Antagonists Cox-2 Diphtheria toxin-conjugated monoclonal antibody IL-13 receptors Gliasite Phase II 131-I Stereotactic radiosurgery versus surgery for single brain metastasis
Publications
-
Karsy M, Sivakumar W, Neil J, Guan J, Moy F, Jensen RL (2015). Meta-analysis of the effect of isocitrate dehydrogenase 1 and 2 mutation on glioblastoma prognosis. Contemp Neurosurg, 37(5), 1-6.
-
Jensen RL (2015). Predicting Outcomes After Glioma Surgery: Model Behavior. World Neurosurg, 84(4), 894-6.
-
Lloyd IE, Clement PW, Salzman KL, Jensen RL, Salama ME, Palmer CA (2015). An unusual and challenging case of HIV-associated primary CNS Lymphoma with Hodgkin-like morphology and HIV encephalitis. Diagn Pathol, 10(1), 152.
-
Karsy M, Guan J, Jensen RL, Huang LW, Colman H (2016). The impact of hypoxia and mesenchymal transistion on glioblastoma patholgenesis and cancer stem cell regulation. World Neurosurg, 88, 222-236.
-
Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016). Combined Hydroxyurea and Verapamil in the Clinical Treatment of Refractory Meningioma: Human and Orthotopic Xenograft Studies. World Neurosurg, 86, 210-9.
